Comparison of commercial allergen ELISA kits for egg detection in food matrices

Smits, Nathalie G.E.; De Dominicis, Emiliano; Koops, Andries J.; Kraan, Rian; Saner, Samim; Van Der Fels-Klerx, H.J.; Hoek-van den Hil, Elise

doi:10.1016/j.heliyon.2023.e19687

Cited by 3 publications

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among them, enzyme-linked immunosorbent assay (ELISA) is the most mature for various targets, which mainly uses enzyme labeled antibody to detect the target. , ELISA has the advantages of high specificity, sensitivity, and simple operation. In addition, ELISA commercial kits have been used for decades in various target detection fields. − However, the screening process for identifying component antibodies is time-consuming, costly, and unstable. , …”

Section: Introductionmentioning

confidence: 99%

Seizing the Hidden Assassin: Current Detection Strategies for Staphylococcus aureus and Methicillin-Resistant S. aureus

Wang,

Yang

2024

J. Agric. Food Chem.

View full text Add to dashboard Cite

Staphylococcus aureus (S. aureus) is a kind of pathogenic bacteria which can lead to food poisoning, hospital, and community infections. S. aureus and methicillin-resistant S. aureus (MRSA) have become headaches for public health worldwide. Therefore, strengthening the detection of S. aureus and MRSA is a critical step to prevent and control its spread and infection. This review summarized multiple detection methods (electrochemical, optical, and other biosensors) for sensitive and efficient detection of nonresistant and resistant S. aureus. First, we have introduced the principle and methods of detection platform for S. aureus and MRSA. We also contrasted various detection strategies. Finally, the current situation and prospect of S. aureus and MRSA detection in the future are explored in depth, and its development direction of detection methods is also predicted. In this review, we found that although biosensors have shown tremendous brilliance in the field of monitoring, they are currently in the experimental stage. It can be certain that we are very close to entering the commercialization stage. The point-of care testing available to nonprofessionals will become a new direction. We firmly believe that the monitoring system will be more perfect and stable and public life will be healthier and safer.

show abstract